Explorer
Will we get nod for vaccine's emergency use? DCGI press conference at 11 am
The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI).
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
India
BREAKING NEWS: Lucknow Sub-Inspector Attacked During Illegal Dairy Drive, Video Goes Viral
BIG UPDATE: BJP Appoints Vinod Tawde UP In-Charge, Tarun Chugh Gujarat & Satish Poonia Punjab
BREAKING NEWS: Gen Alpha Girls March at Midnight in Dhar Over Poor Hostel Facilities
BIG UPDATE: Nitin Nabin Announces BJP’s New Team, 12 Women Get Key Organisational Roles
Breaking: Owaisi Shares Ujjain Temple Bridge Safety Test, Security Guards Seen Jumping
View More
Top Headlines
World
Zambian President Hakainde Hichilema Re-Elected For Second Term
India
Ramdas Athawale Invites CJP Founder Dipke To NDA: 'Join RPI(A), Help Fulfil Ambedkar's Vision'
India
14 Of 28 CMs Face Serious Criminal Cases; Revanth Reddy Tops List, Suvendu Adhikari Second
India
JSSC CGL Cancellation: Why Are Selected Candidates Protesting Against Jharkhand Govt?
Trending News
